Acivir 400 DT tablet

Acivir 400 DT Tablet Pricing and Product Details for Buyers

Get HIV Treatment sells Acivir 400 DT tablet, an acyclovir 400 mg oral tablet manufactured by Cipla. Buyers can place orders directly through the Get HIV Treatment platform. Pricing details are available on the product listing page, where bulk order quantities and strip-level pricing are displayed for resellers and stockists reviewing acyclovir 400 mg price before committing to volume.

Product Identity

Acivir 400 DT tablet contains acyclovir 400 mg as its active ingredient. The full chemical name of the active compound is acyclovir, an antiviral agent belonging to the nucleoside analogue drug category. Cipla manufactures this product. The dispersible tablet format makes Acivir 400 DT a distinct variant within the acyclovir product range, separating it from standard film-coated tablet versions of the same strength.

What This Product Treats

Acyclovir 400 mg is used for the treatment of infections caused by herpes simplex virus and varicella-zoster virus. These include cold sores, genital herpes outbreaks, shingles, and chickenpox. The acyclovir 400 mg tablet used for these viral conditions works across both initial outbreaks and suppression of recurring episodes. This makes it a consistently demanded line for pharmacy buyers and wholesale stockists carrying antiviral ranges.

Available Strengths and Pack Sizes

Acivir 400 DT tablet is available at the 400 mg strength in dispersible tablet form. Buyers sourcing this product should confirm available pack configurations directly through Get HIV Treatment at the time of ordering, as strip counts and carton quantities may vary by batch. The 400 mg strength is the standard unit for this antiviral indication. Stockists building an antiviral shelf should note that this strength covers both conditions the compound is used for, without requiring separate product lines for each.

How It Works

Acyclovir enters virus-infected cells and is converted by a viral enzyme called thymidine kinase into acyclovir monophosphate. Cellular enzymes then convert this into acyclovir triphosphate. This active form works by blocking the viral DNA polymerase enzyme, which the virus needs to copy its DNA and replicate. Without functioning DNA polymerase, the virus cannot produce new copies of itself. The blocking action is selective — it targets the viral enzyme far more strongly than human cellular enzymes. This selectivity is what defines the antiviral activity of acyclovir 400 mg across both herpes simplex and varicella-zoster infections.

The mechanism is well understood. Demand for this compound has been stable for decades.

Side Effect

The side effect of acyclovir 400 mg oral tablet includes nausea, headache, dizziness, and fatigue. Gastrointestinal effects such as vomiting and abdominal discomfort are noted in the product for this drug category. Some patients experience skin reactions including itching or rash. Less common effects include confusion and changes in kidney function, particularly at higher exposures. Side effects are mild and pass on their own for most people taking the 400 mg strength.

Buyers stocking this product should be aware that the side effect is consistent with the broader nucleoside analogue antiviral drug category. This supports stable reseller confidence in the product.

Shelf Life and Storage Requirements

Acivir 400 DT tablet should be stored at temperatures below 25 degrees Celsius. The storage environment should be dry, with low humidity, and away from direct light. The dispersible tablet format requires protection from moisture, making sealed blister or foil packaging essential for maintaining product integrity during stocking and distribution. Buyers ordering in bulk should factor these storage conditions into their warehousing setup. Shelf life details are printed on each pack and should be checked at the time of receipt. Products stored outside the recommended temperature range may degrade before the printed expiry date.

Why Buyers Choose Acivir 400 DT

Acivir 400 DT carries the manufacturing credentials of Cipla, one of the most recognised generic pharmaceutical manufacturers in the international market. The manufacturer’s quality standards and regulatory approvals across multiple markets make this product a reliable choice for resellers sourcing antiviral stock. Acyclovir 400 mg price per strip remains competitive at this strength, which supports margin for wholesale buyers and pharmacy chains alike. Demand for acyclovir-based antivirals holds steady across seasons, making Acivir 400 DT a practical and low-risk addition to any antiviral product range. Buyers reorder consistently. The product has an established track record in global generic markets.